Intervention

glibenclamide

ClinicalTrials.gov intervention label

Clinical trials8

Recruiting0

Common conditions9

Lead sponsors shown7

Clinical trials

8 shown

OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNCT07221799 · 2026-09-01

NOT_YET_RECRUITING

Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 DiabetesNCT01145534 · 2009-01-01

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationNCT00696982 · 2008-06-01

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DMNCT00515801 · 2007-06-01

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00393718 · 2006-11-01

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes MellitusNCT00610038 · 2006-07-01

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesNCT00267683 · 2005-12-01

Ischemic Injury and Ischemic Preconditioning in DiabetesNCT00184821 · 2004-06-01

Common conditions

Diabetes3 Diabetes Mellitus2 Diabetes Mellitus, Type 22 Arterial Stiffness1 Diabetes Mellitus, Insulin-Dependent1 Diabetes Mellitus, Type 11 Ischemia-Reperfusion Injury1 Multiple Sclerosis1 Neuropathic Pain1

Leading sponsors

Novo Nordisk A/S2 Assaf-Harofeh Medical Center1 Assistance Publique - Hôpitaux de Paris1 Federal University of Paraíba1 Radboud University Medical Center1 University Hospital, Basel, Switzerland1 University of Maryland, Baltimore1

Trial status mix

COMPLETED5

NOT_YET_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

PHASE23

PHASE33

PHASE12

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.